In multiple myeloma cells, lovastatin has been shown to induce BiP/Grp78 and CHOP protein expression, the phosphorylation of eIF2α and apoptosis, as well as the cleavage of poly(ADP-ribose) polymerase (PARP) (13). This evidence concerns the gene HSPA5 and plasma cell myeloma.